Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation
Open Access
- 3 March 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (4) , 574-583
- https://doi.org/10.1111/j.1538-7933.2004.00646.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitorsHaemophilia, 1999
- Human recombinant DNA‐derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5‐year study of home therapyHaemophilia, 1999
- Hepatitis A Virus Transmission by Blood Products in the United StatesVox Sanguinis, 1994
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Development of human anti‐murine antibody (HAMA) response in patientsImmunology & Cell Biology, 1990
- Structure of human factor VIIINature, 1984
- Characterization of the human factor VIII geneNature, 1984
- Liver dysfunction in Pennsylvania's multitransfused hemophiliacsDigestive Diseases and Sciences, 1980
- EPIDEMIOLOGY OF HBV-ASSOCIATED DELTA AGENT: GEOGRAPHICAL DISTRIBUTION OF ANTI-DELTA AND PREVALENCE IN POLYTRANSFUSED HBsAg CARRIERSThe Lancet, 1980
- Jaundice and Antibodies Directed against Factors VIII and IX in Patients Treated for Haemophilia or Christmas Disease in the United KingdomBritish Journal of Haematology, 1974